"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust.
.
upgrade to premium
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
. we have let patients down, admits senior northern ireland civil servant
.